A phase 3, double-blind, randomized, placebo-controlled, multicenter study to determine the efficacy and safety of luspatercept (ACE-536) versus placebo in adults who reguire regular red blood cell transfusions due to beta (P) thalassemia-The “BELİEVE” trial

---

Karakaş Z. (Yürütücü), Karaman S.

Diğer Uluslararası Fon Programları, 2016 - 2020

• Proje Türü: Diğer Uluslararası Fon Programları
• Başlama Tarihi: Mayıs 2016
• Bitiş Tarihi: Kasım 2020

Proje Özeti

A phase 3, double-blind, randomized, placebo-controlled, multicenter study to determine the efficacy and safety of luspatercept (ACE-536) versus placebo in adults who reguire regular red blood cell transfusions due to beta (P) thalassemia-The “BELİEVE” trial